ClinicalTrials.govpublic full text
Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
alzheimer disease, dementia alzheimers, dementia, cognitive impairment, mild cognitive impairment, neurodegenerative diseases, neurocognitive disorders, neurocognitive dysfunction, cognitive dysfunction, mental disorder, passive sensing, digital phenotyping
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 865875
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.